Status:
COMPLETED
Effectiveness of DIMS Spectacle as a Function of the Age
Lead Sponsor:
Luca Buzzonetti
Conditions:
Myopia
Eligibility:
All Genders
6-16 years
Brief Summary
Purpose: To evaluate the effectiveness of Defocus Incorporated Multiple Segments (DIMS) in slowing myopia progression as a function of age in pediatric patients. Methods: This was a non-randomized ex...
Detailed Description
Participants were allocated to the study groups, receiving DIMS spectacles, or to the control groups, wearing single vision spectacle lenses.
Eligibility Criteria
Inclusion
- patient age between 6-16 years
- progressive myopia with cycloplegic spherical equivalent (SE) from -0.50 to -4.00 diopters (D)
- astigmatism less than 2.50D, anisometropia under 1.25D
Exclusion
- genetic syndromes suspected (e.g., Stickler, Marfan, etc.)
- systemic diseases
- eye diseases (such as glaucoma, juvenile cataracts, retinal abnormalities, any form of strabismus)
Key Trial Info
Start Date :
December 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2024
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT06556849
Start Date
December 1 2020
End Date
June 30 2024
Last Update
August 20 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Luca Buzzonetti
Rome, Italy